Table 3 Analysis of the correlation between gene mutations and CLNM in patients undergoing BRAF gene testing [n (%)]
Group | Total | Lymph node metastasis | No lymph node metastasis | χ2 | P |
|---|---|---|---|---|---|
BRAF mutation | 79 | 43 (54.4) | 36 (45.6) | 0.109 | 0.741 |
BRAF not mutated | 17 | 10 (58.8) | 7 (41.2) |